What a difference a few months can make – especially during a pandemic. Heading into 2020, biopharma looked like it would be typecast in its typical election year role: the big business scapegoat for everything that’s wrong in health care. There had been the usual big...
Locust Walk partnered with Applied Molecular Transport, Forma Therapeutics, and Goodwin for a live panel on Thursday, July 23rd. Q2 saw a boom in IPOs, while many biopharma companies continue to seek capital in both public and private markets, including multiple...
Locust Walk is partnering with Applied Molecular Transport, Forma Therapeutics, and Goodwin for a live panel on Thursday, July 23rd from 1-2 pm EST entitled “The Unexpected IPO Boom for Biopharma in Q2.” CLICK HERE TO REGISTER Q2 saw a boom in IPOs, while...
Danforth Advisors, Locust Walk, and Mintz joined on Thursday, June 11th from 2-3pm EST for the panel, “Accessing Capital in the Time of COVID: Challenges, Opportunities, and Best Practices.” During the hour, the panel discussed How COVID-19 impacted the...
